MRMD - MariMed beats on revenue
MariMed (OTCQX:MRMD): Q3 Adjusted EBITDA of $ 12,923 Revenue of $33.2M (+146.7% Y/Y) beats by $5.18M. Press Release
For further details see:
MariMed beats on revenueLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get MRMD Alerts
News, Short Squeeze, Breakout and More Instantly...